CN Patent

CN117279923B — 六元杂芳并脲环的衍生物及其应用

Assigned to Medshine Discovery Inc · Expires 2025-09-30 · 1y expired

What this patent protects

一种式(I)所示的六元杂芳并脲环的衍生物及其在制备治疗糖尿病肾病或高血压肾病药物中的应用。

USPTO Abstract

一种式(I)所示的六元杂芳并脲环的衍生物及其在制备治疗糖尿病肾病或高血压肾病药物中的应用。

Drugs covered by this patent

Adempas (RIOCIGUAT) · Bayer

Patent Metadata

Patent number: CN117279923B
Jurisdiction: CN
Classification: —
Expires: 2025-09-30
Drug substance claim: No
Drug product claim: No
Assignee: Medshine Discovery Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.